NAUDER FARADAY, M.D.
Osteopathic Medicine at Wolfe St, Baltimore, MD
License number
Maryland D41860
Category
Osteopathic Medicine
Type
Anesthesiology
License number
Maryland D41860
Category
Osteopathic Medicine
Type
Critical Care Medicine
Address
Address
600 N Wolfe St, Baltimore, MD 21264
Phone
(410) 955-6353
Personal information
See more information about NAUDER FARADAY at radaris.comName
Address
Phone
7904 Ellenham Ave, Towson, MD 21204
824 Bond St, Baltimore, MD 21231
824 Bond St, Baltimore, MD 21231
Organization information
See more information about NAUDER FARADAY at bizstanding.comNauder Faraday MD
600 N Wolfe St, Baltimore, MD 21287
Industry:
Anesthesiology, Obgyn
Phone:
(410) 955-5000 (Phone)
Nauder Faraday
Professional information
Professor Of Anesthesiology At Johns Hopkins University School Of Medicine
Position:
Professor of Anesthesiology at Johns Hopkins University School of Medicine
Location:
Baltimore, Maryland Area
Industry:
Medical Practice
Work:
Johns Hopkins University School of Medicine
since Jul 1993
-
Professor of Anesthesiology
Education:
The Johns Hopkins University 2010 - 2011
MPH, Publich Health/Policy Mt Sinai School of Medicine 1984 - 1988
Doctor of Medicine (MD)
MPH, Publich Health/Policy Mt Sinai School of Medicine 1984 - 1988
Doctor of Medicine (MD)
Dr. Nauder Faraday, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine
Address:
DEPT OF PSYCHIATRY
600 N Wolfe St SUITE B110, Baltimore 21287
(301) 402-2293 (Phone)
600 N Wolfe St SUITE B110, Baltimore 21287
(301) 402-2293 (Phone)
Certifications:
Anesthesiology, 1993, Critical Care Medicine, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
DEPT OF PSYCHIATRY
600 N Wolfe St SUITE B110, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
600 N Wolfe St SUITE B110, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
Mount Sinai School of Medicine
Graduated: 1988
Hospital Of St Raphael
Johns Hopkins Hospital
Mount Sinai School of Medicine
Graduated: 1988
Hospital Of St Raphael
Johns Hopkins Hospital
Novel Endothelially Expressed Dnas And Proteins, And Their Use
US Patent:
2004026, Dec 23, 2004
Filed:
Jun 3, 2004
Appl. No.:
10/482065
Inventors:
Sigrid Scheek - Dossenheim, DE
Holger Hiemisch - Heidelberg, DE
Anthony Lanahan - Bridgewater VT, US
Jean Regard - Palm Beach FL, US
Paul Worley - Baltimore MD, US
Eckart Krupp - Dossenheim, DE
Markus Schwaninger - Mannheim, DE
Nauder Faraday - Baltimore MD, US
Holger Hiemisch - Heidelberg, DE
Anthony Lanahan - Bridgewater VT, US
Jean Regard - Palm Beach FL, US
Paul Worley - Baltimore MD, US
Eckart Krupp - Dossenheim, DE
Markus Schwaninger - Mannheim, DE
Nauder Faraday - Baltimore MD, US
International Classification:
A61K038/17, C07K014/47, C07K007/08
US Classification:
530/324000, 530/326000, 530/327000, 536/023500
Abstract:
The present invention relates to novel, specifically expressed proteins and to nucleic acid sequences or transgenic nucleic acid constructs which encode the proteins. The invention also relates to transgenic organisms or animals which harbor the nucleic acid sequences or recombinant nucleic acid constructs and also to monoclonal or polyclonal antibodies and binding factors which are directed against the isolated proteins. The invention furthermore relates to a process for finding substances which possess specific binding affinity with the proteins according to the invention, and to a process for qualitatively or quantitatively detecting the nucleic acid sequences according to the invention or the proteins according to the invention. The invention furthermore relates to the use of nucleic acid sequences and proteins. The invention also encompasses processes for finding substances which modulate the function of the proteins according to the invention. It also relates to the use of these proteins for producing drugs.
Antithrombotic Agents And Methods Of Use Thereof
US Patent:
2011010, May 5, 2011
Filed:
Jun 19, 2008
Appl. No.:
12/665859
Inventors:
Nauder Faraday - Towson MD, US
Assignee:
The John Hopkins University - Baltimore MD
International Classification:
A61K 39/395, A61K 31/196, A61K 31/407, A61K 31/58, A61K 31/708, A61K 31/7088, A61K 38/02, A61K 38/06, A61K 38/07, A61K 38/16, A61K 38/10, A61K 31/365, C12Q 1/37, C12Q 1/02, A61P 7/02, A61P 9/10, A61P 9/00
US Classification:
4241331, 514563, 514411, 514172, 514 47, 4241581, 514 44 R, 514 138, 514 137, 514468, 435 23, 435 29
Abstract:
The instant invention provides methods and compositions for the treatment, prevention and diagnosis of for example, platelet aggregation or clot formation in a subject. The invention inhibits the activity of decreases the amount of neutrophils in the subject by inhibiting the activity or production of IL-6, interferon-gamma, STAT1, or cathepsin D. The invention addresses decreasing the amount of neutrophils in an attempt to treat subjects that have or are at risk of developing a vascular occlusive disease, an ischemia or reperfusion injury, an acute or chronic inflammatory state, autoimmune disease, myelodysplastic syndrome, tissue injury from surgery or accidental trauma, acute bacterial or viral infection, has undergone a microvascular surgical reconstructive procedure, is receiving granulocyte colony stimulating factor therapy, receiving stem cell therapy, or has sickle cell anemia.